Back to search

Article

Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis

2022-09-15

Abstract excerpt

<h4>Background</h4> High bacterial burden in lung microbiota predicts progression of idiopathic pulmonary fibrosis (IPF). Azithromycin is a macrolide antibiotic known to alter the lung microbiota in several chronic pulmonary diseases and observational studies have shown a positive effect of azithromycin on mortality and hospitalization rate in IPF. However, the effect of AZT on lung microbiota in IPF remain unknow...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
721f582e-53cc-51fb-a392-f40421e908c6
DOI
10.1101/2022.09.14.22279909
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosisDOI 10.1101/2022.09.14.22279909
Select a neighboring publication to make it the new centre.